|
1
|
Webster S, Lawn S, Chan R and Koczwara B:
The role of comorbidity assessment in guiding treatment
decision-making for women with early breast cancer: A systematic
literature review. Support Care Cancer. 28:1041–1050. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wanchai A and Armer JM: A systematic
review association of reflexology in managing symptoms and side
effects of breast cancer treatment. Complement Ther Clin Pract.
38:1010742020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y and Chen Z: Mutation detection and
molecular targeted tumor therapies. STEMedicine. 1:e112020.
View Article : Google Scholar
|
|
4
|
Sun Y, Ji S, Ji H, Liu L and Li C:
Clinical efficacy analysis of transcatheter arterial
chemoembolization (TACE) combined with radiofrequency ablation
(RFA) in primary liver cancer and recurrent liver cancer. J BUON.
24:1402–1407. 2019.PubMed/NCBI
|
|
5
|
Zimmermann M, Pedersoli F, Schulze-Hagen
M, Lurje G, Isfort P, Kuhl C and Bruners P: Salvage RFA in patients
with intrahepatic recurrence after major hepatic surgery for
colorectal cancer liver metastases: Mid-term outcome. Eur Radiol.
30:1221–1227. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Veltri A, Gazzera C, Barrera M, Busso M,
Solitro F, Filippini C and Garetto I: Radiofrequency thermal
ablation (RFA) of hepatic metastases (METS) from breast cancer
(BC): An adjunctive tool in the multimodal treatment of advanced
disease. Radiol Med. 119:327–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carrafiello G, Fontana F, Cotta E, Petullà
M, Brunese L, Mangini M and Fugazzola C: Ultrasound-guided thermal
radiofrequency ablation (RFA) as an adjunct to systemic
chemotherapy for breast cancer liver metastases. Radiol Med.
116:1059–1066. 2011.(In Italian). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ueki A, Okuma T, Hamamoto S, Kageyama K,
Murai K and Miki Y: Combination therapy involving radiofrequency
ablation and targeted chemotherapy with bevacizumab plus paclitaxel
and cisplatin in a rabbit VX2 lung tumor model. BMC Res Notes.
11:2512018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Armstrong DK, Bundy B, Wenzel L, Huang HQ,
Baergen R, Lele S, Copeland LJ, Walker JL and Burger RA;
Gynecologic Oncology Group, : Intraperitoneal cisplatin and
paclitaxel in ovarian cancer. N Engl J Med. 354:34–43. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu RT, Chiang HC, Fu WC, Chien KY, Chung
YM and Horng LY: Formosanin-C, an immunomodulator with antitumor
activity. Int J Immunopharmacol. 12:777–786. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Man S, Li J, Chai H, Fan W, Liu Z
and Gao W: The antitumor effect of formosanin C on HepG2 cell as
revealed by 1H-NMR based metabolic profiling. Chem Biol Interact.
220:193–199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chiang HC, Wang JJ and Wu RT:
Immunomodulating effects of the hydrolysis products of formosanin C
and beta-ecdysone from Paris formosana Hayata. Anticancer Res.
12:1475–1478. 1992.PubMed/NCBI
|
|
13
|
Man S, Gao W, Zhang Y, Liu Z, Yan L, Huang
L and Liu C: Formosanin C-inhibited pulmonary metastasis through
repression of matrix metalloproteinases on mouse lung
adenocarcinoma. Cancer Biol Ther. 11:592–598. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Savas P and Loi S: Metastatic breast
cancer: TIL it is too late. Clin Cancer Res. 26:526–528. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harao M, Forget MA, Roszik J, Gao H,
Babiera GV, Krishnamurthy S, Chacon JA, Li S, Mittendorf EA,
DeSnyder SM, et al: 4-1BB-Enhanced Expansion of CD8+ TIL
from triple-negative breast cancer unveils mutation-specific
CD8+ T cells. Cancer Immunol Res. 5:439–445. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao X, Yang M, Xiao J, Zou J, Huang Q,
Yang K, Zhang B, Yang F, Liu S, Wang H and Bai P: Paris Saponin II
suppresses the growth of human ovarian cancer xenografts via
modulating VEGF-mediated angiogenesis and tumor cell migration.
Cancer Chemother Pharmacol. 73:807–818. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee JC, Su CL, Chen LL and Won SJ:
Formosanin C-induced apoptosis requires activation of caspase-2 and
change of mitochondrial membrane potential. Cancer Sci.
100:503–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dwerryhouse SJ, Soon Lee C, King J,
Magarey C, Schwartz P and Morris DL: Cimetidine does not influence
TIL in breast cancer. Int J Surg Investig. 1:191–194.
1999.PubMed/NCBI
|
|
19
|
Shen J, Xiao Z, Zhao Q, Li M, Wu X, Zhang
L, Hu W and Cho CH: Anti-cancer therapy with TNFα and IFNγ: A
comprehensive review. Cell Prolif. 51:e124412018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alter G, Malenfant JM and Altfeld M:
CD107a as a functional marker for the identification of natural
killer cell activity. J Immunol Methods. 294:15–22. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iacoviello L, Bonaccio M, de Gaetano G and
Donati MB: Epidemiology of breast cancer, a paradigm of the ‘common
soil’ hypothesis. Semin Cancer Biol. Feb 20–2020.(Epub ahead of
print). PubMed/NCBI
|
|
22
|
Malmgren JA, Calip GS, Atwood MK, Mayer M
and Kaplan HG: Metastatic breast cancer survival improvement
restricted by regional disparity: Surveillance, epidemiology, and
end results and institutional analysis: 1990 to 2011. Cancer.
126:390–399. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin M, Verschraegen C, Vincent VH, Patel
SM, George T and Truica CI: Impact of lack of surgery on outcomes
in elderly women with nonmetastatic breast cancer-A surveillance,
epidemiology, and end results 18 population based study. Medicine
(Baltimore). 99:e187452020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee J and Lee MG: Effects of exercise
interventions on breast cancer patients during adjuvant therapy: A
systematic review and meta-analysis of randomized controlled
trials. Cancer Nurs. 43:115–125. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Banys-Paluchowski M, Gruber IV, Hartkopf
A, Paluchowski P, Krawczyk N, Marx M, Brucker S and Hahn M:
Axillary ultrasound for prediction of response to neoadjuvant
therapy in the context of surgical strategies to axillary
dissection in primary breast cancer: A systematic review of the
current literature. Arch Gynecol Obstet. 301:341–353. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Napoletano C, Taurino F, Biffoni M, De
Majo A, Coscarella G, Bellati F, Rahimi H, Pauselli S, Pellicciotta
I, Burchell JM, et al: RFA strongly modulates the immune system and
anti-tumor immune responses in metastatic liver patients. Int J
Oncol. 32:481–490. 2008.PubMed/NCBI
|
|
27
|
Singh S, Bhowmik A and Repaka R: Thermal
analysis of induced damage to the healthy cell during RFA of breast
tumor. J Therm Biol. 58:80–90. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sommer CM, Pallwein-Prettner L, Vollherbst
DF, Seidel R, Rieder C, Radeleff BA, Kauczor HU, Wacker F, Richter
GM, Bücker A, et al: Transarterial embolization (TAE) as add-on to
percutaneous radiofrequency ablation (RFA) for the treatment of
renal tumors: Review of the literature, overview of
state-of-the-art embolization materials and further perspective of
advanced image-guided tumor ablation. Eur J Radiol. 86:143–162.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiao YB, Zhang B and Wu YL: Radiofrequency
ablation versus hepatic resection for breast cancer liver
metastasis: A systematic review and meta-analysis. J Zhejiang Univ
Sci B. 19:829–843. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sofocleous CT, Nascimento RG, Petrovic LM,
Klimstra DS, Gonen M, Brown KT, Brody LA, Covey AM, Thornton RH,
Fong Y, et al: Histopathologic and immunohistochemical features of
tissue adherent to multitined electrodes after RF ablation of liver
malignancies can help predict local tumor progression: Initial
results. Radiology. 249:364–374. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ni JY, Liu SS, Xu LF, Sun HL and Chen YT:
Meta-analysis of radiofrequency ablation in combination with
transarterial chemoembolization for hepatocellular carcinoma. World
J Gastroenterol. 19:3872–3882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo W, He X, Li Z and Li Y: Combination of
Transarterial Chemoembolization (TACE) and Radiofrequency Ablation
(RFA) vs. Surgical Resection (SR) on survival outcome of early
hepatocellular carcinoma: A meta-analysis. Hepatogastroenterology.
62:710–714. 2015.PubMed/NCBI
|
|
33
|
Ahmed M and Goldberg SN: Combination
radiofrequency thermal ablation and adjuvant IV liposomal
doxorubicin increases tissue coagulation and intratumoural drug
accumulation. Int J Hyperthermia. 20:781–802. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu H, Fan ZP, Jiang AN, Di XS, He B, Wang
S, Goldberg SN, Ahmed M, Zhang Q and Yang W: Combination of
intratumoural micellar paclitaxel with radiofrequency ablation:
Efficacy and toxicity in rodents. Eur Radiol. 29:6202–6210. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu J, Man S, Liu Z, Ma L and Gao W: A
synergistic antitumor effect of polyphyllin I and formosanin C on
hepatocarcinoma cells. Bioorg Med Chem Lett. 26:4970–4975. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He QF, Xu Y, Li J, Huang ZM, Li XH and
Wang X: CD8+ T-cell exhaustion in cancer: Mechanisms and new area
for cancer immunotherapy. Brief Funct Genomics. 18:99–106. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hammerl D, Massink MPG, Smid M, van
Deurzen CHM, Meijers-Heijboer HEJ, Waisfisz Q, Debets R and Martens
JWM: Clonality, antigen recognition, and suppression of CD8(+) T
cells differentially affect prognosis of breast cancer subtypes.
Clin Cancer Res. 26:505–517. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang MQ, Hou M, Lin DP and Wang YG:
Proportion and role of CD45+ erythroid progenitor cells in patients
with tongue cancer metastasis. Zhonghua Kou Qiang Yi Xue Za Zhi.
54:445–449. 2019.(In Chinese). PubMed/NCBI
|
|
39
|
Kitahara T, Haraguchi N, Takahashi H,
Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y
and Mori M: Identification and characterization of CD107a as a
marker of low reactive oxygen species in chemoresistant cells in
colorectal cancer. Ann Surg Oncol. 24:1110–1119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kittaneh M, Badve S, Caldera H, Coleman R,
Goetz MP, Mahtani R, Mamounas E, Kalinsky K, Lower E, Pegram M, et
al: Case-based review and clinical guidance on the use of genomic
assays for early-stage breast cancer: Breast Cancer therapy expert
group (BCTEG). Clin Breast Cancer. 20:183–193. 2020. View Article : Google Scholar : PubMed/NCBI
|
